CALYPSO Pilot Study: Machine Learning Based Predictions of Surgical Complications (CALYPSO)

July 2, 2018 updated by: Duke University

Pilot Study for a Clinical Analytical Platform for Surgical Outcomes

This is a pilot study of surgical patients whose postoperative care will be augmented with a personalized risk prediction platform (CALYPSO app).

Study Overview

Detailed Description

CALYPSO is a software platform that uses machine learning techniques to create personalized risk predictions for postoperative complications. Individual risk factors are then linked to best-practice interventions tailored to the individual patient. The investigator aims to test the hypothesis that using CALYPSO-augmented postoperative care will reduce complication rates in patients undergoing elective general surgery. Subjects undergoing surgery will be assigned to the CALYPSO intervention in the postoperative period.

Study Type

Observational

Enrollment (Actual)

200

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • North Carolina
      • Durham, North Carolina, United States, 27710
        • Duke University Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients undergoing high risk general and oncologic abdominal surgery.

Description

Inclusion Criteria:

  • >18 years of age
  • Undergoing elective surgery
  • Undergoing high risk colon, rectal, pancreas, gastric surgery with predicted length of stay greater or equal to 3 days

Exclusion Criteria:

  • Surgeries with less than 3 days of anticipated length of stay (e.g. stoma takedown)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
CALYPSO-augmented
Patients' postoperative care will be augmented with the CALYPSO platform.
Software platform of machine-learning based predictive models of surgical complication.
Previous standard of care based on surgeon judgement alone.
Historical Control
Patients' postoperative care was performed using standard practice, before adopting the CALYPSO platform
Previous standard of care based on surgeon judgement alone.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Thirty Day Overall Complications
Time Frame: 30 days after surgery
30 days after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Thirty Day Mortality
Time Frame: 30 days after surgery
30 days after surgery
Wound Complications
Time Frame: 30 days after surgery
Includes superficial, deep, organ space infections, and wound dehiscence
30 days after surgery
Cardiac Complications
Time Frame: 30 days after surgery
includes myocardial infarction, cardiac arrest
30 days after surgery
Respiratory Complications
Time Frame: 30 days after surgery
includes unplanned reintubation, pneumonia, failure to wean from ventilator >48 hours after surgery
30 days after surgery
Thrombotic complications
Time Frame: 30 days after surgery
includes deep vein thrombosis, pulmonary emobolism
30 days after surgery
Renal Complications
Time Frame: 30 days after surgery
includes acute renal failure, renal failure requiring dialysis
30 days after surgery
urinary tract infections
Time Frame: 30 days after surgery
30 days after surgery
Neurologic complications
Time Frame: 30 days after surgery
includes stroke, peripheral nerve injury, coma
30 days after surgery
Septic complications
Time Frame: 30 days after surgery
includes sepsis and septic shock
30 days after surgery
Unplanned reoperation
Time Frame: 30 days after surgery
30 days after surgery
unplanned readmission
Time Frame: 30 days after surgery
30 days after surgery
bleeding complications
Time Frame: up to 72 hours after surgery
needing at least 1 unit of pRBC
up to 72 hours after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Study Director: Zhifei Sun, MD, Duke University Department of Surgery

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2016

Primary Completion (Actual)

January 1, 2017

Study Completion (Actual)

February 1, 2017

Study Registration Dates

First Submitted

July 7, 2016

First Submitted That Met QC Criteria

July 8, 2016

First Posted (Estimate)

July 11, 2016

Study Record Updates

Last Update Posted (Actual)

July 3, 2018

Last Update Submitted That Met QC Criteria

July 2, 2018

Last Verified

January 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • Pro00072563

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postoperative Infection

Clinical Trials on CALYPSO

Subscribe